Christophe Queva

Company: Oncorus
Job title: Chief Scientific Officer
Seminars:
Optimization of an Oncolytic HSV-1 for the Treatment of Glioblastoma 3:10 pm
Optimization of oHSV backbone 7 Transgenes Development of clinical candidate oncolytic virusRead more
day: Day Two